These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8312552)
21. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511 [TBL] [Abstract][Full Text] [Related]
22. [The mechanism of the proaggregant action on the thrombocytes of RNA and DNA molecules]. Zakharian RA; Rukhkian LA Nauchnye Doki Vyss Shkoly Biol Nauki; 1990; (2):31-5. PubMed ID: 1693862 [TBL] [Abstract][Full Text] [Related]
23. Modulation of platelet and leucocyte function by a Chinese herbal formulation as compared with conventional antiplatelet agents. Zhao L; Gaudry L; Dunkley S; Brighton T; Guo ZX; Ye ZL; Luo RZ; Chesterman CN Platelets; 2008 Feb; 19(1):24-31. PubMed ID: 18231935 [TBL] [Abstract][Full Text] [Related]
24. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase. Liu FC; Liao CH; Chang YW; Liou JT; Day YJ Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675 [TBL] [Abstract][Full Text] [Related]
26. Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation. Nyby MD; Sasaki M; Ideguchi Y; Wynne HE; Hori MT; Berger ME; Golub MS; Brickman AS; Tuck ML J Pharmacol Exp Ther; 1996 Aug; 278(2):503-9. PubMed ID: 8768697 [TBL] [Abstract][Full Text] [Related]
27. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. Sheu JR; Hsiao G; Chou PH; Shen MY; Chou DS J Agric Food Chem; 2004 Jul; 52(14):4414-8. PubMed ID: 15237945 [TBL] [Abstract][Full Text] [Related]
28. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro. Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514 [TBL] [Abstract][Full Text] [Related]
29. N-Ethylmaleimide induces disaggregation of platelets preaggregated by ADP and thrombin and decreases cytoplasmic calcium level. Samal AB; Loiko EN Biochemistry (Mosc); 2000 Feb; 65(2):230-6. PubMed ID: 10713553 [TBL] [Abstract][Full Text] [Related]
30. Delayed inhibition of agonist-induced granulocyte-platelet aggregation after low-dose sevoflurane inhalation in humans. Wacker J; Lucchinetti E; Jamnicki M; Aguirre J; Härter L; Keel M; Zaugg M Anesth Analg; 2008 Jun; 106(6):1749-58. PubMed ID: 18499605 [TBL] [Abstract][Full Text] [Related]
31. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization. Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins. Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966 [TBL] [Abstract][Full Text] [Related]
33. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation. Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652 [TBL] [Abstract][Full Text] [Related]
34. [A decrease in the stimulated level of free intracellular calcium in thrombocytes during refractoriness]. Pozin EIa; Popov EG; Gavrilov IIu; Gabbasov ZA; Krotov SN Biull Eksp Biol Med; 1988 Dec; 106(12):672-4. PubMed ID: 2850037 [TBL] [Abstract][Full Text] [Related]
35. Effect of prostaglandins and drotaverine on ADP-induced platelet aggregation. Losonczy H; Nagy I; Gregus Z Acta Med Acad Sci Hung; 1974; 31(3-4):157-63. PubMed ID: 4469713 [No Abstract] [Full Text] [Related]
37. [Experimental research on the action of isoptin and alkylenediamine derivatives on the aggregation capacity and the membrane-bound calcium level of thrombocytes]. Mironiuk EP; Manevich EM; Piotrovskiĭ LB; Dumpis MA Farmakol Toksikol; 1987; 50(2):42-6. PubMed ID: 3582633 [TBL] [Abstract][Full Text] [Related]
38. [Action of toxic staphylococcal (St. aureus) substances on the functional properties of the thrombocytes]. Maleev VV; Poliakova AM; Astrina OS; Mol'kov NIu; Buriachkovskaia LI Biull Eksp Biol Med; 1986 Dec; 102(12):678-81. PubMed ID: 3801619 [TBL] [Abstract][Full Text] [Related]
39. [Effect of bacterial toxins on microcirculation (experimental research)]. Shalygina NB; Shepeleva GK; Astrina OS; Lomazova KhD; Poliakova AM Arkh Patol; 1987; 49(2):27-32. PubMed ID: 3105520 [TBL] [Abstract][Full Text] [Related]
40. [Phosphoinositide metabolism in endothelial cells of the human umbilical vein exposed to Y. pestis toxin]. Cherkasova TD; Iurkiv VA; Pokrovskiĭ VI Biull Eksp Biol Med; 1994 Feb; 117(2):153-5. PubMed ID: 8012018 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]